P-212 Factors affecting median PFS in patients with advanced, non-resectable well differentiated pancreatic neuroendocrine tumors treated initially with octreotide LAR - real world data
- Resource Type
- Source
- Annals of Oncology. 31:S159
- Subject
Oncology medicine.medical_specialty business.industry Hematology Neuroendocrine tumors medicine.disease Octreotide lar Well differentiated Internal medicine medicine In patient business Real world data - Language
- ISSN
- 0923-7534